4th Quarter - Report
THORN RUN PARTNERS for NOVARTIS CORPORATION
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid reimbursement of biosimilars and drugs. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19, Lower Costs, More Cures Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| MICHAEL O'SHEA MCCARTHY | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to pharmaceutical pricing and biosimilars. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19, Lower Costs, More Cures Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| MICHAEL O'SHEA MCCARTHY | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.